Global Pharma major Lupin Limited and Zentiva Group, a pan-European pharmaceutical company, have entered into a license and ...

Lupin Ltd has entered into a License and Supply Agreement with Zentiva, k.s., for commercialization of Lupin's biosimilar Certolizumab Pegol.

Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for ...

It is indicated for various diseases including heumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...

Lupin Ltd., Biocon Ltd., Granules India Ltd., shares gained despite the sentiment for overall pharmaceutical stocks got affected after US President Donald Trump's threats.

Asian Paints sells stake in Akzo Nobel India, GAIL extends gas agreement, SEBI proposes new guidelines, companies announce ...

Lupin and Zentiva announce a license and supply agreement for the commercialization of biosimilar Certolizumab Pegol across ...

Pharmaceutical major Lupin Limited has announced the strategic spin-off of its consumer healthcare business, LupinLife ...

Lupin & Zentiva ink licensing and supply agreement for commercializing biosimilar Certolizumab Pegol: Our Bureau, Mumbai Wednesday, July 9, 2025, 16:20 Hrs [IST] Global Pharma maj ...

Certolizumab Pegol is indicated for the treatment of patients with rheumatoid arthritis, polyarticular juvenile idiopathic ...

Mumbai: Global pharma major Lupin Limited, has announced the strategic carve-out of its consumer healthcare business, ...

This is eligible for 180 days of generic drug exclusivity. The company will manufacture the product at its facility situated ...